Comparison of sodium nitroprusside and adenosine for fractional flow reserve assessment: a systematic review and meta-analysis

References

• Fearon WF, Nishi T, De Bruyne B, et al. Clinical outcomes and cost-effectiveness of fractional flow reserve-guided percutaneous coronary intervention in patients with stable coronary artery disease: three-year follow-up of the FAME 2 trial (fractional flow reserve versus angiography for multivessel evaluation). FAME 2 trial investigators. Circulation. 2018;137(5):480–487.
   PubMed Web of Science ®Google Scholar
• Pim AL, Tonino BDB, Pijls NHJ, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. For the FAME study investigators. N Engl J Med. 2009;360:213–224.
   PubMed Web of Science ®Google Scholar
• Pijls NH, De Bruyne B, Peels K, et al. Measurement of fractional flow reserve to assess the functional severity of coronary artery stenoses. N Engl J Med. 1996;334:1703–1708.
   PubMed Web of Science ®Google Scholar
• De Bruyne B, Pijls NH, Bartunek J, et al. Fractional flow reserve in patients with prior myocardial infarction. Circulation. 2001;104:157–162.
   PubMed Web of Science ®Google Scholar
• Pijls NH, Van Gelder B, Van der Voort P, et al. Fractional flow reserve: a useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation. 1995;92:3183–3193.
   PubMed Web of Science ®Google Scholar
• Pijls NH, van Son JA, Kirkeeide RL, et al. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation. 1993;87:1354–1367.
   PubMed Web of Science ®Google Scholar
• Patel HR, Shah P, Bajaj S, et al. Intracoronary adenosine-induced ventricular arrhythmias during fractional flow reserve (FFR) measurement: case series and literature review. Cardiovasc Interv and Ther. 2017;32(4):374–380.
   PubMed Web of Science ®Google Scholar
• Shah AH, Chan W, Seidelin PH. Ventricular fibrillation precipitated by intracoronary adenosine during fractional flow reserve assessment – a cautionary tale. Heart Lung Circ. 2015;24(11):e173–5.
   PubMed Web of Science ®Google Scholar
• Cerqueira MD, Verani MS, Schwaiger M, et al. Safety profile of adenosine stress perfusion imaging: results from the adenoscan multicenter trial registry. J Am Coll Cardiol. 1994;23:384–389.
   PubMed Web of Science ®Google Scholar
• Parham WA, Bouhasin A, Ciaramita JP, et al. Coronary hyperemic dose responses of intracoronary sodium nitroprusside. Circulation. 2004;109:1236–1243.
   PubMed Web of Science ®Google Scholar
• Rudzinski W, Waller A, Rusovici A, et al. Comparison of efficacy and safety of intracoronary sodium nitroprusside and intravenous adenosine for assessing fractional flow reserve. Catheter Cardiovasc Interv. 2013;81:540–544.
   PubMed Web of Science ®Google Scholar
• Leone AM, Porto I, De Caterina AR, et al. Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study. JACC Cardiovasc Interv. 2012;5(4):402–408.
   PubMed Web of Science ®Google Scholar
• Lee J, Singh N, Nyotowidjojo I, et al. Comparison of regadenoson and nitroprusside to adenosine for measurement of fractional flow reserve: a systematic review and meta-analysis. Cardiovasc Revasc Med. 2017;(July):S1553–8389(17)30244–0. DOI:10.1016/j.carrev.2017.07.004
   Google Scholar
• Safi M, Namazi MH, Fooladi E, et al. Comparison of fractional flow reserve measurements using intracoronary adenosine versus intracoronary sodium nitroprusside infusions in moderately stenotic coronary artery lesions. Cardiovasc Revasc Med. 2016;17:441–443.
   PubMed Web of Science ®Google Scholar
• Pedroni P, Sarmiento RA, Solernó R, et al. Safety and efficacy of intracoronary sodium nitroprusside for the assessment of coronary fractional flow reserve. Indian Heart J. In-press.
   Google Scholar
• Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocol (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647.
   PubMed Web of Science ®Google Scholar
• Elbourne DR, Altman DG, Higgins JP, et al. Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol. 2002 Feb;31(1):140–149.
   PubMed Web of Science ®Google Scholar
• Follmann D, Elliott P, Suh I, et al. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol. 1992 Jul;45(7):769–773.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 Sep;7(3):177–188.
   PubMedGoogle Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003 Sep 6;327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997 Sep 13;315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Schwarzer G. Meta: a R package for meta-analysis. R News. 2007;7:40–45.
   Google Scholar
• Lindefjeld D, Díaz J, Cardenal R, et al. Nitroprusiato: una droga confiable para la estimación de la reserva de flujo fraccional coronario. Rev Chil Cardiol. 2014;33:20–26.
   Google Scholar
• Li S, Deng J, Wang X, et al. Efficiencies of intracoronary sodium nitroprusside on fractional flow reserve measurement. Int J Clin Exp Med. 2015;8(2):2679–2683.
   PubMed Web of Science ®Google Scholar
• Zimmermann FM, Ferrara A, Johnson NP, et al. Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. Eur Heart J. 2015;36(45):3182–3188.
   PubMed Web of Science ®Google Scholar
• Kato D1, Takashima H, Waseda K, et al. Feasibility and safety of intracoronary nicorandil infusion as a novel hyperemic agent for fractional flow reserve measurements. Heart Vessels. 2015;30(4):477–483.
   PubMed Web of Science ®Google Scholar
• Johnson N, Jeremias A, Zimmermann F, et al. Continuum of vasodilator stress from rest to contrast medium to adenosine hyperemia for fractional flow reserve assessment. J Am Coll Cardiol Intv. 2016;9:757–767.
   Google Scholar
• Sen S, Escaned J, Malik IS, et al. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave–intensity analysis. Results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) Study. JACC. 2012;59(15):1392–1402.
   Google Scholar
• Davies JE, Sen S, Dehbi H, et al. Use of the instantaneous wave-free ratio or fractional flow reserve in PCI. N Engl J Med. 2017;376:1824–1834.
   PubMed Web of Science ®Google Scholar
• Götberg M, Christiansen EH, Gudmundsdottir IJ, et al. Instantaneous wave-free ratio versus fractional flow reserve to guide PCI. N Engl J Med. 2017;376(19):1813–1823.
   PubMed Web of Science ®Google Scholar
• Maini R, Moscona J, Katigbak P, et al. Instantaneous wave-free ratio as an alternative to fractional flow reserve in assessment of moderate coronary stenoses: a meta-analysis of diagnostic accuracy studies. Cardiovasc Revasc Med. 2017 Dec 27 (Epub ahead of print). DOI:10.1016/j.carrev.2017.12.014
   PubMed Web of Science ®Google Scholar
• Johnson NP, Tóth GG, Lai D, et al. Prognostic value of fractional flow reserve linking physiologic severity to clinical outcomes. JACC. 2014;64(16):1641–1654.
   Google Scholar
• Rigattieri S, Biondi Zoccai G, Sciahbasi A, et al. Meta-analysis of head-to-head comparison of intracoronary versus intravenous adenosine for the assessment of fractional flow reserve. Am J Cardiol. 2017;120:563–568. Article in press.
   PubMed Web of Science ®Google Scholar